 Home > Active Ingredient News > Blood System > Leukemia: Identification of biomarkers related to endothelial dysfunction and thromboembolism in acute lymphoblastic leukemia

Leukemia: Identification of biomarkers related to endothelial dysfunction and thromboembolism in acute lymphoblastic leukemia

 Last Update: 2021-09-12
 Source: Internet
 Author: User

Tags

all star foams

growth

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Past studies have shown that after adopting the best treatment strategies, the five-year overall survival rates of childhood and adolescent acute lymphoblastic leukemia (ALL) exceed 90% and 75%, respectively

The five-year overall survival rates of childhood and adolescent acute lymphoblastic leukemia (ALL) exceed 90% and 75%, respectively

TE mainly originates from veins and is one of the most common and serious toxic reactions.

diagnosis

Previous studies have found that endothelial dysfunction (ED) plays a vital role in thrombosis

Endothelial dysfunction (ED) plays a vital role in thrombosis

Research flow chart

In this retrospective study, the researchers aimed to analyze the above three biomarkers (TM, Sdc-1, VEGFR-1) in prospectively collected blood samples and 55 cases and 165 cases treated under the NOPHO ALL 2008 regimen.

The researchers aimed to analyze the three biomarkers (TM, Sdc-1, VEGFR-1) in prospectively collected blood samples and 55 cases and 165 time-matched controls treated under the NOPHO ALL 2008 regimen for thromboembolism The correlation between risks

Individual sample measurement of endothelial biomarkers

In an adjusted analysis of age, gender, and risk group, the researchers found that increased levels of TM and VEGFR-1 were independently associated with an increase in the incidence of thromboembolism

Increased levels of TM and VEGFR-1 are independently associated with an increase in the incidence of thromboembolism

Endothelial dysfunction and thromboembolism in children, adolescents, and young adults with acute lymphoblastic leukemia.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gadusol Powder Gadusol76663-30-4

CAS No.: 76663-30-4

Industrial Grade

$1-1.01/G FOB

Food Additive Iron fumarate for Nutritional Iron Supplements

CAS No.: 141-01-5

Pharmacy Grade

$24-26/G FOB

Aminobenzoic Acid CAS 56-91-7

CAS No.: 56-91-7

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.